No Data
No Data
San Yuan Biology (301206.SZ) distributed 1.5 yuan for every 10 shares in the semi-annual period, with the registration date of September 26th.
San Yuan Biology (301206.SZ) announced that the company will implement a mid-year equity distribution in 2024, with a distribution of 10...
San Yuan Biology (301206.SZ): The company's alogluzin project is currently in the stage of market promotion and initial development.
San Yuan Bio (301206.SZ) stated on the investor interaction platform on September 9th that the investment return period of the new project is affected by various factors such as market demand, production efficiency, technological progress, and market competition. The company's Arotinolol project is currently in the stage of market promotion and initial development, and it takes time for the returns to gradually become evident. The company will continue to optimize production and promotion strategies in order to achieve better investment returns as soon as possible.
San Yuan Biological (301206.SZ): Nongfu Spring is one of the company's important clients.
Sanyuan Biology (301206.SZ) stated on the investor interaction platform on September 9th that Nongfu Spring is one of the company's important customers, and the two parties have maintained a long-term stable cooperative relationship. Regarding the specific purchasing situation of major customers, the company will strictly comply with the relevant disclosure regulations for compliance disclosure.
Sanyuan Biotech (301206.SZ): Cumulatively repurchased 0.23% of the shares.
On September 2nd, Gelonghui announced that as of August 31, 2024, the company had repurchased a total of 460,700 shares through a dedicated account for share buyback, accounting for 0.23% of the total share capital of the company. The highest fill price was 24.48 yuan/share, and the lowest fill price was 23.70 yuan/share. The total accumulated fill amount was 11,112,503.76 yuan (excluding transaction fees). The progress of this buyback conforms to the company's share buyback plan and relevant laws and regulations.
Sanyuan Biology: 2024 Semi-Annual Report
Sanyuan Biology: 2024 Semi-Annual Report Summary
No Data
No Data